Important Additional Information will be Filed with the U.S. Securities and Exchange Commission (“SEC”)
This filing relates solely to preliminary communications made before the commencement of a planned tender offer by Accipiter Corp. (“Purchaser”), a wholly-owned subsidiary of Stryker Corporation (“Stryker”), for all of the issued and outstanding shares of common stock, $0.001 par value per share, of Invuity, Inc. (“Invuity”) for $7.40 per share in cash, to be commenced pursuant to the Agreement and Plan of Merger, dated September 10, 2018, by and among Stryker, Purchaser and Invuity.
Neither this tender offer statement on Schedule TO nor the press release filed herewith is an offer to purchase, a solicitation of an offer to sell, or a recommendation to sell shares of Invuity. Purchaser has not yet commenced the tender offer to purchase Invuity’s outstanding stock described in this tender offer statement on Schedule TO.
Upon commencement of the tender offer to purchase Invuity’s outstanding stock, Stryker and Purchaser will file with the SEC a tender offer statement on Schedule TO and related exhibits, including the offer to purchase, letter of transmittal and other tender offer documents. Following commencement of the tender offer, Invuity will file with the SEC a tender offer solicitation/recommendation statement on Schedule14D-9. These documents will contain important information about Stryker, Purchaser, Invuity, the transaction and related matters. Investors are urged to read each of these documents carefully when they are available.
Investors will be able to obtain free copies of the tender offer statement, the tender offer solicitation/recommendation statement and other documents filed with the SEC by Stryker, Purchaser and Invuity through the website maintained by the SEC at www.sec.gov. In addition, investors will be able to obtain free copies of these documents by contacting Stryker’s Investor Relations department at katherine.owen@stryker.com, or Invuity’s Investor Relations department at 444 De Haro St., San Francisco, CA 94107, Attention: Investor Relations.
| | |
Exhibit No. | | Description |
| |
99.1 | | Stryker Press Release issued September 11, 2018 |